2020 Journal Article Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institutionRoberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x |
2020 Journal Article 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancerRoberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2020). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 655-656. doi: 10.1007/s00259-020-04944-2 |
2019 Journal Article Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysisPerera, Marlon, Papa, Nathan, Roberts, Matthew, Williams, Michael, Udovicich, Cristian, Vela, Ian, Christidis, Daniel, Bolton, Damien, Hofman, Michael S., Lawrentschuk, Nathan and Murphy, Declan G. (2019). Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. European Urology, 77 (4), 403-417. doi: 10.1016/j.eururo.2019.01.049 |
2015 Journal Article The emerging threat of multidrug-resistant Gram-negative bacteria in urologyZowawi, Hosam M., Harris, Patrick N. A., Roberts, Matthew J., Tambyah, Paul A., Schembri, Mark A., Pezzani, M. Diletta, Williamson, Deborah A. and Paterson, David L. (2015). The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology, 12 (10), 570-584. doi: 10.1038/nrurol.2015.199 |
2015 Journal Article Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancerRoberts, Matthew J., Chow, Clement W., Schirra, Horst J., Richards, Renee, Buck, Marion, Selth, Luke A., Doi, Suhail A. R., Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate, 75 (5), 539-549. doi: 10.1002/pros.22942 |
2015 Journal Article Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysisPerera, Marlon, Roberts, Matthew J., Doi, Suhail A. R. and Bolton, Damien (2015). Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. European Urology, 67 (4), 704-713. doi: 10.1016/j.eururo.2014.10.031 |
2014 Journal Article Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysisRoberts, Matthew J., Williamson, Deborah A., Hadway, Paul, Doi, Suhail A. R., Gardiner, Robert A. and Paterson, David L. (2014). Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. International Journal of Antimicrobial Agents, 43 (4), 301-309. doi: 10.1016/j.ijantimicag.2014.01.008 |
2025 Journal Article Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterialsKoo, Kevin M., Lim, Malcom, Simpson, Peter, Lakhani, Sunil, Roberts, Matthew, Masud, Mostafa, Puttick, Simon and Rose, Stephen (2025). Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials. ChemNanoMat, 11 (1) e202400449. doi: 10.1002/cnma.202400449 |
2024 Journal Article Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneityMcGeorge, Stephen, Pattison, David A., Dhiantravan, Nattakorn, Thomas, Paul A., Yaxley, John W. and Roberts, Matthew J. (2024). Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity. Uro, 5 (1), 1-11. doi: 10.3390/uro5010001 |
2024 Journal Article Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approachCollin, Harry, Roberts, Matthew J., Keogh, Kandice, Siriwardana, Amila and Basto, Marnique (2024). Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach. BJUI Compass, 6 (1) e427, e427. doi: 10.1002/bco2.427 |
2024 Journal Article A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardwareMehawed, Georges, Roberts, Matthew J., Bugeja, Jessica, Dowling, Jason, Stewart, Kate, Gunasena, Rivindi, Malczewski, Frances, Rukin, Nicholas J. and Murray, Rebecca (2024). A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware. Journal of Clinical Medicine, 13 (23) 7384, 1-11. doi: 10.3390/jcm13237384 |
2024 Conference Publication The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610 |
2024 Journal Article The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019 |
2024 Conference Publication The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons. |
2024 Journal Article Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristicsRoberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482 |
2024 Journal Article The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohortTariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Pelecanos, Anita, Gan, Chun Loo, Goh, Jeffrey C., Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2024). The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort. European Urology Focus, 10 (5), 770-778. doi: 10.1016/j.euf.2023.12.004 |
2024 Journal Article Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual careLindsay, Daniel, Schofield, Penelope, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Collins, Louisa G. (2024). Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care. European Urology Oncology. doi: 10.1016/j.euo.2024.08.005 |
2024 Journal Article Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate CancerEmmett, Louise, Papa, Nathan, Hope, Thomas A., Fendler, Wolfgang, Calais, Jeremie, Burger, Irene, Eiber, Matthias, Barbato, Francesco, Moon, Daniel, Counter, William, John, Nikeith, Xue, Alan, Franklin, Anthony, Thompson, James, Rasiah, Kris, Frydenberg, Mark, Yaxley, John, Buteau, James, Agrawal, Shikha, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Woo, Henry, Hsiao, Edward, Sutherland, Thomas, Perry, Elyse, Stricker, Phillip, Hofman, Michael S. ... Murphy, Declan (2024). Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer. The Journal of urology, 212 (2), 299-309. doi: 10.1097/JU.0000000000004010 |
2024 Journal Article EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intentCornford, Philip, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, van Leenders, Geert J.L.H., Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Tilki, Derya (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent. European Urology, 86 (2), 148-163. doi: 10.1016/j.eururo.2024.03.027 |
2024 Journal Article ChatGPT can help guide and empower patients after prostate cancer diagnosisCollin, Harry, Keogh, Kandice, Basto, Marnique, Loeb, Stacy and Roberts, Matthew J. (2024). ChatGPT can help guide and empower patients after prostate cancer diagnosis. Prostate Cancer and Prostatic Diseases, 1-3. doi: 10.1038/s41391-024-00864-6 |